SPATS2L Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85807
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human
Applications
Validated:
Western Blot
Cited:
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human SPATS2L. Peptide sequence: VDKAVQAFVDGSAIQVLKEWNMTGKKKNNKRKRSKSKQHQGNKDAKDKVE The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for SPATS2L Antibody
![Western Blot: SPATS2L Antibody [NBP2-85807]](https://resources.bio-techne.com/images/products/SPATS2L-Antibody-Western-Blot-NBP2-85807-img0001.jpg "Western Blot: SPATS2L Antibody [NBP2-85807]")
Western Blot: SPATS2L Antibody [NBP2-85807]
Western Blot: SPATS2L Antibody [NBP2-85807] - Host: Rabbit. Target Name: SPATS2L. Sample Tissue: Human NCI-H226 Whole Cell. Antibody Dilution: 1ug/mlApplications for SPATS2L Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SPATS2L
Alternate Names
DKFZp564A2416, DNA polymerase transactivated protein 6, DNA polymerase-transactivated protein 6, DNAPTP6SGNP, SPATS2-like protein, spermatogenesis associated, serine-rich 2-like, stress granule and nucleolar protein
Gene Symbol
SPATS2L
Additional SPATS2L Products
Product Specific Notices for SPATS2L Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...